By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quidel announced on Friday that the US Food and Drug Administration has cleared for marketing two of its molecular tests, one for human metapneumovirus and the other for influenza A and B, making them the San Diego company's first FDA-cleared MDx tests.

The Quidel Molecular hMPV Assay is the first molecular test from the company to receive FDA 510(k) clearance, it said, adding it was launched in Europe after getting CE marked in September 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.